ProShare Advisors’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $492K | Buy |
|
|||||
|
2025
Q1 | $88.6K | Sell |
|
|||||
|
2024
Q4 | $135K | Buy |
|
|||||
|
2024
Q3 | $89.2K | Buy |
|
|||||
|
2024
Q2 | $68.4K | Sell |
|
|||||
|
2024
Q1 | $235K | Buy |
|
|||||
|
2023
Q4 | $188K | Buy |
|
|||||
|
2023
Q3 | $143K | Buy |
|
|||||
|
2023
Q2 | $199K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $215K | Buy |
|
|||||
|
2022
Q3 | $345K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $270K | Buy |
|
|||||
|
2021
Q4 | $377K | Buy |
|